` Comparison: 1AD vs ATXS - Alpha Spread

1AD
vs
ATXS

Over the past 12 months, 1AD has underperformed ATXS, delivering a return of -40% compared to the ATXS's +99 113% growth.

Start AI Comparison

Smart Verdict
AI-Powered

Not Sure Which Stock Wins?
Let AI Decide.
1AD
ATXS
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Smart Verdict is Ready!
See Who Stands Out.
All the numbers, charts, and metrics summarized into one smart verdict.
Stocks Compared:
Show Comparison Results
Summarizing...
We need a little more time to summarize the results

Valuation Comparison

1AD Intrinsic Value
0.008 AUD
Undervaluation 48%
Intrinsic Value
Price
ATXS Intrinsic Value
75.09 USD
Overvaluation 99%
Intrinsic Value
Price
Company Last Price Intrinsic Value DCF Value Multiples-Based Value Wall St Target
Adalta Ltd
ASX:1AD
0.004 AUD
Astria Therapeutics Inc
NASDAQ:ATXS
5 298 USD
No Stocks Selected

Compare the stock's valuation with its competitors.

Select Stocks to Compare
Valuation Scenario:
Bear Case
Base Case
Bull Case

Growth Comparison

Growth Over Time
1AD, ATXS

1AD
ATXS
Add Stock
Revenue
www.alphaspread.com
No Stocks Selected

Compare company's financials with its competitors.

Select Stocks to Compare
Company LTM Historical Growth Growth Streak % Positive Years Max Drawdown Volatility Forecasted Growth
3 Years 5 Years 10 Years 1 Year 3 Years
Adalta Ltd
Revenue
Astria Therapeutics Inc
Revenue

All metrics are calculated based on data from the last 10 years.

No Stocks Selected

Compare company's financials with its competitors.

Select Stocks to Compare

Profitability Comparison

Free Cash Flow
1AD, ATXS

1AD
ATXS
Add Stock
Free Cash Flow
www.alphaspread.com
No Stocks Selected

Compare company's free cash flow with its competitors.

Select Stocks to Compare
Company LTM Average Historical Growth FCF Margin Conversion
3 Years 5 Years 3 Years 5 Years 10 Years
Adalta Ltd
ASX:1AD
Astria Therapeutics Inc
NASDAQ:ATXS
No Stocks Selected

Compare company's free cash flow with its competitors.

Select Stocks to Compare
What is Free Cash Flow?

Gross Margin

1AD
0%
ATXS
0%
LTM 3Y Avg 5Y Avg 10Y Avg
Adalta Ltd
Astria Therapeutics Inc

Operating Margin

1AD
-653%
ATXS
-19 335.7%
LTM 3Y Avg 5Y Avg 10Y Avg
Adalta Ltd
Astria Therapeutics Inc

Net Margin

1AD
-696.2%
ATXS
-17 568%
LTM 3Y Avg 5Y Avg 10Y Avg
Adalta Ltd
Astria Therapeutics Inc

FCF Margin

1AD
-390%
ATXS
-17 042.9%
LTM 3Y Avg 5Y Avg 10Y Avg
Adalta Ltd
Astria Therapeutics Inc

ROE

1AD
7 314.3%
ATXS
-43.1%
LTM 3Y Avg 5Y Avg 10Y Avg
Adalta Ltd
Astria Therapeutics Inc

ROA

1AD
-208.4%
ATXS
-39.2%
LTM 3Y Avg 5Y Avg 10Y Avg
Adalta Ltd
Astria Therapeutics Inc

ROIC

1AD
565.9%
ATXS
-462.1%
LTM 3Y Avg 5Y Avg 10Y Avg
Adalta Ltd
Astria Therapeutics Inc

ROCE

1AD
-573.9%
ATXS
-45.9%
LTM 3Y Avg 5Y Avg 10Y Avg
Adalta Ltd
Astria Therapeutics Inc

Solvency Comparison

No Stocks Selected

Compare company's equity waterfall with its competitors.

Select Stocks to Compare
Balance Sheet Comparison
No Stocks Selected

Compare company's balance sheet with its competitors.

Select Stocks to Compare

Stocks Performance

Stocks Performance
1AD, ATXS

Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
1AD, ATXS

Loading
1AD
ATXS
Difference
www.alphaspread.com

Performance By Year
1AD, ATXS

Loading
1AD
ATXS
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Not Sure Which Stock Wins?
Let AI Decide
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Compare 1AD to other stocks
PNEXF
Pharnext SCA
More expensive
vs 1AD
ABBV
Abbvie Inc
More expensive
vs 1AD
EXAS
Exact Sciences Corp
More expensive
vs 1AD
AMGN
Amgen Inc
More expensive
vs 1AD
Unlock Full Access to Alpha Spread
Create Free Account
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett